46 companies

Ascendis Pharma

Market Cap: US$10.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$168.17

7D

-2.2%

1Y

23.2%

Alnylam Pharmaceuticals

Market Cap: US$42.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$317.50

7D

-1.4%

1Y

24.6%

ALTEOGEN

Market Cap: ₩22.4t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩419,000.00

7D

12.5%

1Y

59.6%

Akeso

Market Cap: HK$98.6b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$109.80

7D

19.4%

1Y

194.4%

Exelixis

Market Cap: US$12.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$43.51

7D

-0.3%

1Y

96.4%

Insmed

Market Cap: US$18.4b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

New

INSM

US$96.14

7D

-1.5%

1Y

36.8%

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥75.8b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

603392

CN¥59.93

7D

-0.4%

1Y

-8.7%

argenx

Market Cap: €28.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€464.10

7D

-2.4%

1Y

11.6%

Vertex Pharmaceuticals

Market Cap: US$118.0b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

VRTX

US$466.36

7D

3.1%

1Y

-4.0%

Eli Lilly

Market Cap: US$693.8b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

LLY

US$777.66

7D

0.2%

1Y

-16.6%

BeOne Medicines

Market Cap: US$28.5b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$244.47

7D

-0.3%

1Y

69.1%

Sandoz Group

Market Cap: CHF 19.0b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

SDZ

CHF 44.04

7D

2.6%

1Y

29.9%

GSK

Market Cap: UK£57.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK

UK£14.14

7D

0.1%

1Y

-6.4%

Illumina

Market Cap: US$15.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ILMN

US$99.27

7D

1.1%

1Y

-6.9%

AstraZeneca

Market Cap: UK£160.3b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£103.40

7D

-0.6%

1Y

-13.4%

Innovent Biologics

Market Cap: HK$140.8b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

1801

HK$82.35

7D

5.0%

1Y

125.0%

Daiichi Sankyo Company

Market Cap: JP¥5.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

4568

JP¥3,135.00

7D

-5.5%

1Y

-46.7%

AbbVie

Market Cap: US$331.4b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

ABBV

US$189.77

7D

-0.1%

1Y

12.9%

Galderma Group

Market Cap: CHF 29.6b

Operates as a dermatology company worldwide.

GALD

CHF 124.50

7D

7.8%

1Y

70.5%

Orion Oyj

Market Cap: €9.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€65.65

7D

3.4%

1Y

60.8%

Sartorius Stedim Biotech

Market Cap: €19.6b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

DIM

€201.40

7D

-1.0%

1Y

28.3%

Incyte

Market Cap: US$13.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$67.67

7D

-1.5%

1Y

11.5%

Neurocrine Biosciences

Market Cap: US$12.7b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

NBIX

US$128.74

7D

0.6%

1Y

-10.2%

Celltrion

Market Cap: ₩38.8t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

A068270

₩175,500.00

7D

9.4%

1Y

2.4%

Teva Pharmaceutical Industries

Market Cap: US$19.3b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

TEVA

US$16.63

7D

-0.06%

1Y

5.2%

Lonza Group

Market Cap: CHF 39.2b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

LONN

CHF 555.60

7D

-1.5%

1Y

10.1%

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 449.95

7D

2.6%

1Y

-53.4%

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

500420

₹3,323.45

7D

-2.7%

1Y

13.2%

Natera

Market Cap: US$21.7b

A diagnostics company, provides molecular testing services worldwide.

NTRA

US$158.48

7D

-1.4%

1Y

44.8%

Recordati Industria Chimica e Farmaceutica

Market Cap: €11.0b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

REC

€53.55

7D

-0.9%

1Y

9.7%

Takeda Pharmaceutical

Market Cap: JP¥6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

4502

JP¥4,393.00

7D

-0.02%

1Y

3.7%

Qiagen

Market Cap: US$10.3b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

QGEN

US$47.85

7D

-0.7%

1Y

16.1%

Viatris

Market Cap: US$10.8b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$9.26

7D

0.9%

1Y

-14.3%

Tempus AI

Market Cap: US$10.1b

Operates as a healthcare technology company.

TEM

US$58.51

7D

-1.1%

1Y

67.2%

Sino Biopharmaceutical

Market Cap: HK$96.0b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

1177

HK$5.37

7D

2.1%

1Y

89.8%

Roche Holding

Market Cap: CHF 206.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

ROG

CHF 257.70

7D

-1.2%

1Y

5.4%

Page 1 of 2